Clinical Trial Update: A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study evaluating Teclistamab in combination with Mezigdomide for multiple myeloma. The trial is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Mezigdomide (mezigdomide)
• TECVAYLI (TECLISTAMAB-CQYV)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Multiple Myeloma | Phase 1 | Status: RECRUITING